Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-02-13
2010-10-05
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S235800, C514S248000, C514S252190, C514S254010, C514S253090, C514S254020, C514S254030, C514S254050, C514S307000, C514S321000, C514S326000, C514S414000, C514S423000, C544S121000, C544S142000, C544S235000, C544S335000, C544S357000, C544S295000, C544S366000, C544S367000, C544S368000, C544S369000, C544S372000, C546S146000, C546S199000, C546S226000, C546S279100, C548S453000
Reexamination Certificate
active
07807672
ABSTRACT:
Disclosed are the ERK inhibitors of formula 1.0:and the pharmaceutically acceptable salts and solvates thereof. Q is a piperidine or piperazine ring that can have a bridge or a fused ring. The piperidine ring can have a double bond in the ring. All other substituents are as defined herein. Also disclosed are methods of treating cancer using the compounds of formula 1.0.
REFERENCES:
patent: 6831175 (2004-12-01), Li et al.
patent: 6897231 (2005-05-01), Bhagwat et al.
patent: 7208513 (2007-04-01), Bhagwat et al.
patent: 7211594 (2007-05-01), Bhagwat et al.
patent: 7220771 (2007-05-01), Bhagwat et al.
patent: 7429609 (2008-09-01), Ohi et al.
patent: 2002/0103229 (2002-08-01), Bhagwat et al.
patent: 2003/0055068 (2003-03-01), Bebbington et al.
patent: 2004/0127536 (2004-07-01), Bhagwat et al.
patent: 2004/0127538 (2004-07-01), Oinuma et al.
patent: 2005/0009876 (2005-01-01), Bhagwat et al.
patent: 2005/0107386 (2005-05-01), Narla et al.
patent: 2005/0107457 (2005-05-01), Bhagwat et al.
patent: 2007/0060616 (2007-03-01), Bennett et al.
patent: 2007/0149484 (2007-06-01), Claus et al.
patent: 2007/0191604 (2007-08-01), Cooper et al.
patent: 2007/0265333 (2007-11-01), Fu et al.
patent: 2008/0004287 (2008-01-01), Ma et al.
patent: 2008/0007509 (2008-01-01), Lankhorst et al.
patent: 2009/0011284 (2009-01-01), Wang et al.
patent: 2009/0062355 (2009-03-01), Iizawa et al.
patent: 2009/0118284 (2009-05-01), Cooper et al.
patent: 2 306 108 (1997-04-01), None
patent: 2 323 845 (1998-07-01), None
patent: WO 9745412 (1997-12-01), None
patent: WO 9903498 (1999-01-01), None
patent: WO 9910325 (1999-03-01), None
patent: WO 0156557 (2001-08-01), None
patent: WO 0157022 (2001-08-01), None
patent: WO 0168619 (2001-09-01), None
patent: WO 0172721 (2001-10-01), None
patent: WO 02/10137 (2002-02-01), None
patent: WO 0222604 (2002-03-01), None
patent: WO 0222610 (2002-03-01), None
patent: WO 0250065 (2002-06-01), None
patent: WO 02/064586 (2002-08-01), None
patent: WO 02088090 (2002-11-01), None
patent: WO 02088097 (2002-11-01), None
patent: WO 03011854 (2003-02-01), None
patent: WO 03011855 (2003-02-01), None
patent: WO 03035626 (2003-05-01), None
patent: WO 03/091246 (2003-11-01), None
patent: WO 03099212 (2003-12-01), None
patent: WO 2004026867 (2004-04-01), None
patent: WO 2004083203 (2004-09-01), None
patent: WO 2005002673 (2005-01-01), None
patent: WO 2005063258 (2005-07-01), None
patent: WO 2005/100342 (2005-10-01), None
patent: WO 2005100338 (2005-10-01), None
patent: WO 2005/113541 (2005-12-01), None
patent: WO 2005113546 (2005-12-01), None
patent: WO 2006040569 (2006-04-01), None
patent: WO 2006071644 (2006-07-01), None
patent: WO 2006136008 (2006-12-01), None
patent: WO 2007044401 (2007-04-01), None
patent: WO 2007044420 (2007-04-01), None
patent: WO 2008121742 (2008-10-01), None
patent: WO 2008/156739 (2008-12-01), None
patent: WO 2008154241 (2008-12-01), None
patent: WO 2009/105500 (2009-08-01), None
PCT International Search Report dated Jul. 9, 2007, for corresponding PCT Application No. PCT/US2007/003665.
Cooper Alan
Deng Yongqi
Desai Jagdish
Doll Ronald
Dong Youhao
Bernhardt Emily
Jeanette Henry C.
Schering Corporation
LandOfFree
Compounds that are ERK inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds that are ERK inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds that are ERK inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4180154